CAS No. |
114471-18-0 |
中文名称 |
(S)-3-((S)-2-((2S,3S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-(2-((S)-2-(2-((4R,7S,13S,16R)-16-(2-((S)-2-(2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-1-(L-丝氨酰)吡咯烷-2-羧酰胺基)-6-氨基己酰胺基)-4-(甲硫基)丁酰胺基)-3-甲基丁酰胺基)-5-氨基-5-氧代戊酰胺基)乙酰胺基)-3-羟基丙酰胺基)乙酰胺基)-13-苄基-7-(3-胍基丙基)-6,9,12,15-四氧代-1,2-二硫-5,8,11,14-四氮杂环十七烷-4-羧酰胺基)乙酰胺基)-4-甲基戊酰胺基)乙酰胺基)-3-羟基丙酰胺基)-3-羟基丙酰胺基)-3-羟基丙酰胺基)-3-羟基丙酰胺基)-3-甲基戊酰胺基)-5-胍基戊酰胺基)-4-(((S)-1-(((S)-6-氨基-1-(((S)-6-氨基-1-(((S)-1-(((S)-1-(((S)-1-(((S)-1-(((S)-1-羧基-2-(1H-咪唑-4-基)乙基)氨基)-5-胍基-1-氧代戊烷-2-基)氨基)-5-胍基-1-氧代戊烷-2-基)氨基)-4-甲基-1-氧代戊烷-2-基)氨基)-3-甲基-1-氧代丁烷-2-基)氨基)-1-氧代己烷-2-基)氨基)-1-氧代己烷-2-基)氨基)-4-(甲硫基)-1-氧代丁烷-2-基)氨基)-4-氧代丁酸--乙酸(1/1) |
英文名称 |
(S)-3-((S)-2-((2S,3S)-2-((S)-2-((S)-2-((S)-2-((S)-2-(2-((S)-2-(2-((4R,7S,13S,16R)-16-(2-((S)-2-(2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-1-(L-seryl)pyrrolidine-2-carboxamido)-6-aminohexanamido)-4-(methylthio)butanamido)-3-methylbutanamido)-5-amino-5-oxopentanamido)acetamido)-3-hydroxypropanamido)acetamido)-13-benzyl-7-(3-guanidinopropyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraazacycloheptadecane-4-carboxamido)acetamido)-4-methylpentanamido)acetamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-3-methylpentanamido)-5-guanidinopentanamido)-4-(((S)-1-(((S)-6-amino-1-(((S)-6-amino-1-(((S)-1-(((S)-1-(((S)-1-(((S)-1-(((S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxohexan-2-yl)amino)-1-oxohexan-2-yl)amino)-4-(methylthio)-1-oxobutan-2-yl)amino)-4-oxobutanoic acid--acetic acid (1/1) |
别名 |
BNP-32 BNP (1-32), human |
标准英文名 |
(S)-3-((S)-2-((2S,3S)-2-((S)-2-((S)-2-((S)-2-((S)-2-(2-((S)-2-(2-((4R,7S,13S,16R)-16-(2-((S)-2-(2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-1-(L-seryl)pyrrolidine-2-carboxamido)-6-aminohexanamido)-4-(methylthio)butanamido)-3-methylbutanamido)-5-amino-5-oxopentanamido)acetamido)-3-hydroxypropanamido)acetamido)-13-benzyl-7-(3-guanidinopropyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraazacycloheptadecane-4-carboxamido)acetamido)-4-methylpentanamido)acetamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-3-methylpentanamido)-5-guanidinopentanamido)-4-(((S)-1-(((S)-6-amino-1-(((S)-6-amino-1-(((S)-1-(((S)-1-(((S)-1-(((S)-1-(((S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxohexan-2-yl)amino)-1-oxohexan-2-yl)amino)-4-(methylthio)-1-oxobutan-2-yl)amino)-4-oxobutanoic acid--acetic acid (1/1) |
MDL No. |
MFCD00133149 |
分子式 |
C145H248N50O44S4 |
分子量 |
3524.15
|
精确分子量 |
3521.76
|
SMILES |
CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O)C(C)C |
标准SMILES |
CC(O)=O.CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CC2C=CC=CC=2)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O |
用途 |
Nesiritide is indicated for the treatment of acute and chronic heart failure. Due to its rapid onset of action when administered intravenously, it is particularly suitable for patients with acute heart failure. It may provide significant therapeutic benefits in heart failure patients who respond poorly to other treatments. Clinical studies have demonstrated that nesiritide improves clinical symptoms, hemodynamics, and prognosis in patients with heart failure. |
InChIKey |
FJULFJFRGUHITK-INJFIXSDSA-N |